Anushua Sinha is an Infectious Disease physician affiliated with Merck & Co.. OpenAlex indexes 71 publications with 1,851 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
185 S Orange Ave
New Jersey Medical School - Umdnj, Msb F506
Newark, NJ 071032757
Telephone
973-972-4422Registry record last updated 8 Jul 2007.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Protease Inhibitor100%Symtuza100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2004 per NIH RePORTER. The latest:
- CONSEQUENCES OF GROUP B STREPTOCOCCAL PROPHYLAXIS
Univ of Med/dent of Nj-Nj Medical School
FY2004$28,080K23AI001832
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease
New England Journal of Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”